Prostate-specific membrane antigen (PSMA) is a prominent target given that it is upregulated on prostate cancer cell surfaces as well as the neovasculature of all major solid tumors (Chang et al., 1999). This evidence concerns the gene FOLH1 and Familial prostate cancer.